v3.26.1
Condensed Statement of Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series C Convertible Preferred Stock
Accumulated Deficit
Beginning Balance at Dec. 31, 2024   $ 13,578 $ 29,801 $ 52,847        
Beginning Balance, Shares at Dec. 31, 2024   4,902,814 4,335,051 4,890,123        
Beginning Balance at Dec. 31, 2024 $ (70,630)         $ 541   $ (71,171)
Beginning Balance, Shares at Dec. 31, 2024         4,139,219      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock             $ 600  
Beginning Balance at Dec. 31, 2024   $ 13,578 $ 29,801 $ 52,847        
Beginning Balance, Shares at Dec. 31, 2024   4,902,814 4,335,051 4,890,123        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of Series C convertible preferred stock       $ 12,503        
Issuance of Series C convertible preferred stock, Shares       1,117,743        
Ending Balance at Mar. 31, 2025   $ 13,578 $ 29,801 $ 65,350        
Ending Balance, Shares at Mar. 31, 2025   4,902,814 4,335,051 6,007,866        
Beginning Balance at Dec. 31, 2024 (70,630)         541   (71,171)
Beginning Balance, Shares at Dec. 31, 2024         4,139,219      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Deemed dividend related to issuance of Series C convertible preferred stock (584)         (584)    
Vesting of early exercised stock options 10         10    
Vesting of early exercised stock options, Shares         8,960      
Exercise of vested stock options 149         149    
Exercise of vested stock options, Shares         422,364      
Stock-based compensation expense 175         175    
Net loss (5,729)             (5,729)
Ending Balance at Mar. 31, 2025 (76,609)         291   (76,900)
Ending Balance, Shares at Mar. 31, 2025         4,570,543      
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of Series C convertible preferred stock, Shares       1,117,743        
Ending Balance at Mar. 31, 2026   $ 0 $ 0 $ 0        
Ending Balance, Shares at Mar. 31, 2026   0 0 0        
Beginning Balance at Dec. 31, 2025 $ 98,869         199,674   (100,805)
Beginning Balance, Shares at Dec. 31, 2025 26,604,505       26,604,505      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of early exercised stock options $ 10         10    
Vesting of early exercised stock options, Shares         8,961      
Exercise of vested stock options $ 436         436    
Cashless exercise of warrants         30,366      
Exercise of vested stock options, Shares 537,669       537,669      
Stock-based compensation expense $ 1,629         1,629    
Net loss (8,696)             (8,696)
Ending Balance at Mar. 31, 2026 $ 92,248         $ 201,749   $ (109,501)
Ending Balance, Shares at Mar. 31, 2026 27,181,501       27,181,501